Multisystem Inflammatory Syndrome in Children: Two Years' Worth of Learning

Seth McKenzie Alexander1,2,3, John Bryan Lykes1,3, Christopher Nassef1,3

  • 1Department of Pediatrics, Division of Pediatric Critical Care and Hospital Medicine, WakeMed Children's Hospital, Raleigh, NC, USA.

Clinical Pediatrics
|June 13, 2023
PubMed

Insights

Certain inflammatory markers like erythrocyte sedimentation rate (ESR) and ferritin may predict Multisystem Inflammatory Syndrome in Children (MIS-C) severity. Long-term cardiac outcomes for MIS-C patients appear favorable, with most abnormalities resolving within 30 days.

Area of Science:

  • Pediatric infectious diseases
  • Cardiology
  • Immunology

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition following SARS-CoV-2 infection.
  • Risk stratification and long-term outcomes for MIS-C require further investigation.
  • Understanding predictors of severity and cardiac involvement is crucial for managing MIS-C.

Purpose of the Study:

  • To identify associations between serologic markers and MIS-C severity.
  • To evaluate long-term cardiac outcomes in children with MIS-C.
  • To determine if inflammatory markers can predict the need for interventions or cardiac dysfunction.

Main Methods:

  • Retrospective case series of 46 children diagnosed with MIS-C.
  • Statistical analysis including Pearson's chi-squared tests and correlation analysis.
  • Assessment of erythrocyte sedimentation rate (ESR), ferritin levels, and echocardiographic findings (ejection fraction).

Main Results:

  • Elevated ESR (>30 mm/h) correlated with pediatric intensive care unit (PICU) admission.
  • Higher ESR (>50 mm/h) and lower ferritin (<175.6 ng/mL) were associated with vasopressor use.
  • A negative correlation was observed between ESR and ejection fraction (EF), indicating potential cardiac impact.

Conclusions:

  • Inflammatory markers like ESR and ferritin may help predict MIS-C severity and the need for interventions.
  • While cardiac dysfunction can occur, most echocardiographic abnormalities resolve within 30 days.
  • MIS-C does not appear to be associated with significant long-term complications at one year.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
492
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
362